Skip to main content

Peer Review reports

From: A phase 1–2, prospective, double blind, randomized study of the safety and efficacy of Sulfasalazine for the treatment of progressing malignant gliomas: study protocol of [ISRCTN45828668]

Original Submission
14 Nov 2005 Submitted Original manuscript
18 Nov 2005 Author responded Author comments - Pierre Robe
Resubmission - Version 2
18 Nov 2005 Submitted Manuscript version 2
15 Dec 2005 Author responded Author comments - Pierre Robe
Resubmission - Version 3
15 Dec 2005 Submitted Manuscript version 3
15 Dec 2005 Author responded Author comments - Pierre Robe
Resubmission - Version 4
15 Dec 2005 Submitted Manuscript version 4
20 Dec 2005 Author responded Author comments - Pierre Robe
Resubmission - Version 5
20 Dec 2005 Submitted Manuscript version 5
17 Jan 2006 Author responded Author comments - Pierre Robe
Resubmission - Version 6
17 Jan 2006 Submitted Manuscript version 6
Publishing
31 Jan 2006 Editorially accepted
31 Jan 2006 Article published 10.1186/1471-2407-6-29

You can find further information about peer review here.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us